Cullinan Therapeutics Inc (CGEM)

Mar 04, 2026

[SCHEDULE 13G] Cullinan Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Mar 04, 2026

Mar 03, 2026

CGEM: Transformational milestones and pivotal data for autoimmune and AML programs expected by 2026 - TradingView

Mar 03, 2026

Feb 27, 2026

CGEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Feb 27, 2026

Feb 27, 2026

Cullinan Therapeutics (CGEM) Stock Analysis: Exploring A 101% Upside Potential - DirectorsTalk Interviews

Feb 27, 2026

Feb 27, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 7.6%Here's Why - MarketBeat

Feb 27, 2026

Feb 27, 2026

Cullinan Therapeutics executives to join major healthcare conference fireside chats - Traders Union

Feb 27, 2026

Feb 26, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $25,169.20 in Stock - MarketBeat

Feb 26, 2026

Feb 26, 2026

Insider Sell: Jennifer Michaelson Sells Shares of Cullinan Thera - GuruFocus

Feb 26, 2026

Feb 26, 2026

Cullinan Therapeutics (CGEM) CSO sells 1,780 shares in Rule 10b5-1 trade - Stock Titan

Feb 26, 2026

Feb 26, 2026

CGEM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 26, 2026

Feb 25, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 1,752 Shares - MarketBeat

Feb 25, 2026

Feb 25, 2026

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells 3,601 Shares of Stock - MarketBeat

Feb 25, 2026

Feb 25, 2026

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $66,301.54 in Stock - MarketBeat

Feb 25, 2026

Feb 25, 2026

Cullinan Therapeutics (NASDAQ:CGEM) CEO Nadim Ahmed Sells 13,515 Shares - MarketBeat

Feb 25, 2026

Feb 25, 2026

Cullinan Therapeutics (CGEM) CSO sells 5,353 shares under 10b5-1 plan - Stock Titan

Feb 25, 2026

Feb 25, 2026

Cullinan Therapeutics (CGEM) CMO sells shares to cover RSU tax bill - Stock Titan

Feb 25, 2026

Feb 25, 2026

[Form 4] Cullinan Therapeutics, Inc. Insider Trading Activity - Stock Titan

Feb 25, 2026

Feb 25, 2026

Jennifer Michaelson sells shares under 10b5-1 (CGEM) - Stock Titan

Feb 25, 2026

Feb 25, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Hits New 12-Month HighWhat's Next? - MarketBeat

Feb 25, 2026

Feb 24, 2026

Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Feb 24, 2026

Feb 23, 2026

Cullinan Therapeutics: Thesis Strengthening For T-Cell Engager Specialist (NASDAQ:CGEM) - Seeking Alpha

Feb 23, 2026

Feb 23, 2026

Jennifer Michaelson Sells 11,742 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jeffrey Alan Jones Sells 4,982 Shares - MarketBeat

Feb 23, 2026

Feb 23, 2026

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) CFO Sells 4,398 Shares of Stock - MarketBeat

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics (CGEM) CMO sells 4,982 shares for RSU tax obligations - Stock Titan

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics (CGEM) CSO exercises options and sells 11,742 shares - Stock Titan

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics (CGEM) CLO sells 3,742 shares to cover tax - Stock Titan

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics (CGEM) CEO sells shares to cover RSU tax bill - Stock Titan

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics (CGEM) CFO sells shares to cover RSU tax bill - Stock Titan

Feb 23, 2026

Feb 23, 2026

CGEM (NASDAQ: CGEM) Form 144 shows 1,752-share proposed resale; insider sales listed - Stock Titan

Feb 23, 2026

Feb 23, 2026

Cullinan Therapeutics Inc expected to post a loss of 81 cents a shareEarnings Preview - TradingView

Feb 23, 2026

Feb 23, 2026

Is Cullinan Therapeutics Inc. benefiting from innovation trendsCEO Change & Detailed Earnings Play Strategies - mfd.ru

Feb 23, 2026

Feb 22, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Cut to Hold at Zacks Research - Defense World

Feb 22, 2026

Feb 21, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Stock Rating Lowered by Zacks Research - MarketBeat

Feb 21, 2026

Feb 20, 2026

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech With 120% Upside Potential - DirectorsTalk Interviews

Feb 20, 2026

Feb 20, 2026

Will Cullinan Therapeutics Inc. stock recover faster than peersJuly 2025 PreEarnings & Smart Money Movement Alerts - mfd.ru

Feb 20, 2026

Feb 20, 2026

What is the long term forecast for Cullinan Therapeutics Inc. stockJuly 2025 Sentiment & Detailed Earnings Play Alerts - mfd.ru

Feb 20, 2026

Feb 20, 2026

What is Cullinan Therapeutics Inc.’s valuation compared to sectorJuly 2025 Selloffs & Real-Time Stock Price Movement Reports - mfd.ru

Feb 20, 2026

Feb 20, 2026

Jennifer Michaelson proposes sale of 8,000 shares | CGEM SEC FilingForm 144 - Stock Titan

Feb 20, 2026

Feb 20, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Research Coverage Started at Citigroup - Defense World

Feb 20, 2026

Feb 19, 2026

Cullinan Therapeutics Touts 2026 “Defining Year” as T-Cell Engager, Zipalertinib Catalysts Near - MarketBeat

Feb 19, 2026

Feb 19, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Hits New 1-Year HighTime to Buy? - MarketBeat

Feb 19, 2026

Feb 19, 2026

CGEM: 2026 will bring major clinical and regulatory milestones across oncology and autoimmune programs - TradingView

Feb 19, 2026

Feb 19, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Earns Buy Rating from Analysts at Citigroup - MarketBeat

Feb 19, 2026

Feb 19, 2026

Cullinan Therapeutics (CGEM) Expected to Announce Quarterly Earnings on Thursday - Defense World

Feb 19, 2026

Feb 19, 2026

Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 19, 2026

Feb 18, 2026

Cullinan Therapeutics to Participate in Fireside Chat at the Citi 2026 Virtual Oncology Leadership Summit - The Globe and Mail

Feb 18, 2026

Feb 18, 2026

Cullinan leaders join Citi virtual oncology fireside chat on Feb. 19 - Stock Titan

Feb 18, 2026

Feb 17, 2026

Citigroup Initiates Coverage of Cullinan Therapeutics (CGEM) with Buy Recommendation - Nasdaq

Feb 17, 2026

Feb 17, 2026

Citigroup Initiates Buy Coverage on CGEM with $33 Target | CGEM Stock News - GuruFocus

Feb 17, 2026

Feb 17, 2026

Citigroup Initiates Cullinan Therapeutics at Buy With $33 Price Target - marketscreener.com

Feb 17, 2026

Feb 15, 2026

Can Cullinan Therapeutics Inc. ride the EV waveMarket Risk Report & Low Risk High Reward Trade Ideas - mfd.ru

Feb 15, 2026

Feb 14, 2026

CGEM PE Ratio & Valuation, Is CGEM Overvalued - Intellectia AI

Feb 14, 2026

Feb 14, 2026

US Market Wrap: What’s the RSI of Cullinan Therapeutics Inc. stockWeekly Trade Recap & High Conviction Buy Zone Picks - mfd.ru

Feb 14, 2026

Feb 13, 2026

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring A 159.97% Potential Upside - DirectorsTalk Interviews

Feb 13, 2026

Feb 13, 2026

CGEM Should I Buy - Intellectia AI

Feb 13, 2026

Feb 13, 2026

Cullinan Therapeutics Tees Up Catalyst-Heavy 2026 With Q2 CLN-978 Data and AML Fast Track Momentum - MarketBeat

Feb 13, 2026

Feb 12, 2026

CGEM: 2026 will deliver key data for T cell engagers in autoimmune and AML, driving major portfolio catalysts - TradingView

Feb 12, 2026

Feb 12, 2026

CGEM: 2026 will deliver major clinical catalysts in autoimmune and oncology, backed by strong financials - TradingView

Feb 12, 2026

Feb 11, 2026

Layoff Watch: How does SNDA perform in inflationary periodsGlobal Markets & Safe Entry Zone Identification - baoquankhu1.vn

Feb 11, 2026

Feb 11, 2026

Retail Trends: Whats the profit margin of Cullinan Therapeutics IncProduct Launch & Intraday High Probability Alerts - baoquankhu1.vn

Feb 11, 2026

Feb 11, 2026

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight - Yahoo Finance

Feb 11, 2026

Feb 08, 2026

Cullinan Therapeutics (NASDAQ:CGEM) Rating Lowered to Sell at Wall Street Zen - MarketBeat

Feb 08, 2026